Table of Content

1 Study Coverage
1.1 Paroxysmal Nocturnal Hemoglobinuria Drug Product Introduction
1.2 Market by Type
1.2.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Eculizumab
1.2.3 Ravulizumab
1.2.4 Others
1.3 Market by Application
1.3.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Region
2.2.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Region (2018-2024)
2.2.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Region (2024-2029)
2.2.4 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Region (2018-2029)
2.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region
2.4.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2018-2024)
2.4.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2024-2029)
2.4.4 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Manufacturers
3.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Paroxysmal Nocturnal Hemoglobinuria Drug in 2022
3.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Manufacturers
3.2.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Paroxysmal Nocturnal Hemoglobinuria Drug Revenue in 2022
3.3 Global Key Players of Paroxysmal Nocturnal Hemoglobinuria Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Paroxysmal Nocturnal Hemoglobinuria Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Paroxysmal Nocturnal Hemoglobinuria Drug, Product Offered and Application
3.8 Global Key Manufacturers of Paroxysmal Nocturnal Hemoglobinuria Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type
4.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Historical Sales by Type (2018-2024)
4.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Type (2018-2029)
4.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type
4.2.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Type (2018-2029)
4.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Price by Type
4.3.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Price by Type (2018-2024)
4.3.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application
5.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Historical Sales by Application (2018-2024)
5.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application (2018-2029)
5.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application
5.2.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Application (2018-2029)
5.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Price by Application
5.3.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Price by Application (2018-2024)
5.3.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Type
6.1.1 US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2029)
6.1.2 US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2018-2029)
6.2 US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Application
6.2.1 US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2029)
6.2.2 US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2018-2029)
6.3 US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Country
6.3.1 US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2029)
6.3.3 US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Type
7.1.1 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2029)
7.1.2 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2018-2029)
7.2 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Application
7.2.1 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2029)
7.2.2 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2018-2029)
7.3 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Country
7.3.1 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2029)
7.3.3 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Paroxysmal Nocturnal Hemoglobinuria Drug Market Size
8.1.1 China Paroxysmal Nocturnal Hemoglobinuria Drug Sales (2018-2029)
8.1.2 China Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029)
8.2 China Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Application
8.2.1 China Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2029)
8.2.2 China Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Type
9.1.1 Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2029)
9.1.2 Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2018-2029)
9.2 Asia Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Application
9.2.1 Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2029)
9.2.2 Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2018-2029)
9.3 Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region
9.3.1 Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Region (2018-2029)
9.3.3 Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Apellis Pharmaceuticals
11.1.1 Apellis Pharmaceuticals Company Information
11.1.2 Apellis Pharmaceuticals Overview
11.1.3 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Apellis Pharmaceuticals Recent Developments
11.2 Alexion Pharmaceuticals Inc
11.2.1 Alexion Pharmaceuticals Inc Company Information
11.2.2 Alexion Pharmaceuticals Inc Overview
11.2.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Alexion Pharmaceuticals Inc Recent Developments
11.3 Akari Therapeutics Plc
11.3.1 Akari Therapeutics Plc Company Information
11.3.2 Akari Therapeutics Plc Overview
11.3.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Akari Therapeutics Plc Recent Developments
11.4 CinnaGen Co
11.4.1 CinnaGen Co Company Information
11.4.2 CinnaGen Co Overview
11.4.3 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 CinnaGen Co Recent Developments
11.5 Ra Pharmaceuticals Inc
11.5.1 Ra Pharmaceuticals Inc Company Information
11.5.2 Ra Pharmaceuticals Inc Overview
11.5.3 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ra Pharmaceuticals Inc Recent Developments
11.6 Amgen Inc
11.6.1 Amgen Inc Company Information
11.6.2 Amgen Inc Overview
11.6.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Amgen Inc Recent Developments
11.7 Achillion Pharmaceuticals Inc
11.7.1 Achillion Pharmaceuticals Inc Company Information
11.7.2 Achillion Pharmaceuticals Inc Overview
11.7.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Achillion Pharmaceuticals Inc Recent Developments
11.8 Alnylam Pharmaceuticals Inc
11.8.1 Alnylam Pharmaceuticals Inc Company Information
11.8.2 Alnylam Pharmaceuticals Inc Overview
11.8.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Alnylam Pharmaceuticals Inc Recent Developments
11.9 F. Hoffmann-La Roche Ltd
11.9.1 F. Hoffmann-La Roche Ltd Company Information
11.9.2 F. Hoffmann-La Roche Ltd Overview
11.9.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 F. Hoffmann-La Roche Ltd Recent Developments
11.10 Novartis AG
11.10.1 Novartis AG Company Information
11.10.2 Novartis AG Overview
11.10.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis AG Recent Developments
11.11 Regeneron Pharmaceuticals Inc
11.11.1 Regeneron Pharmaceuticals Inc Company Information
11.11.2 Regeneron Pharmaceuticals Inc Overview
11.11.3 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Regeneron Pharmaceuticals Inc Recent Developments
11.12 BIOCAD
11.12.1 BIOCAD Company Information
11.12.2 BIOCAD Overview
11.12.3 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BIOCAD Recent Developments
11.13 Samsung Bioepis
11.13.1 Samsung Bioepis Company Information
11.13.2 Samsung Bioepis Overview
11.13.3 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Samsung Bioepis Recent Developments
11.14 Amyndas Pharmaceuticals
11.14.1 Amyndas Pharmaceuticals Company Information
11.14.2 Amyndas Pharmaceuticals Overview
11.14.3 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Amyndas Pharmaceuticals Recent Developments
11.15 Teva Pharmaceutical Industries Ltd.
11.15.1 Teva Pharmaceutical Industries Ltd. Company Information
11.15.2 Teva Pharmaceutical Industries Ltd. Overview
11.15.3 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.16 LGM Pharma.
11.16.1 LGM Pharma. Company Information
11.16.2 LGM Pharma. Overview
11.16.3 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 LGM Pharma. Recent Developments
11.17 Lannett
11.17.1 Lannett Company Information
11.17.2 Lannett Overview
11.17.3 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Lannett Recent Developments
11.18 NorthStar Rx LLC
11.18.1 NorthStar Rx LLC Company Information
11.18.2 NorthStar Rx LLC Overview
11.18.3 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 NorthStar Rx LLC Recent Developments
11.19 Abbott
11.19.1 Abbott Company Information
11.19.2 Abbott Overview
11.19.3 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Abbott Recent Developments
11.20 Par Pharmaceutical
11.20.1 Par Pharmaceutical Company Information
11.20.2 Par Pharmaceutical Overview
11.20.3 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Par Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Paroxysmal Nocturnal Hemoglobinuria Drug Industry Chain Analysis
12.2 Paroxysmal Nocturnal Hemoglobinuria Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Paroxysmal Nocturnal Hemoglobinuria Drug Production Mode & Process
12.4 Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Marketing
12.4.1 Paroxysmal Nocturnal Hemoglobinuria Drug Sales Channels
12.4.2 Paroxysmal Nocturnal Hemoglobinuria Drug Distributors
12.5 Paroxysmal Nocturnal Hemoglobinuria Drug Customers
13 Market Dynamics
13.1 Paroxysmal Nocturnal Hemoglobinuria Drug Industry Trends
13.2 Paroxysmal Nocturnal Hemoglobinuria Drug Market Drivers
13.3 Paroxysmal Nocturnal Hemoglobinuria Drug Market Challenges
13.4 Paroxysmal Nocturnal Hemoglobinuria Drug Market Restraints
14 Key Findings in The Global Paroxysmal Nocturnal Hemoglobinuria Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Eculizumab
Table 3. Major Manufacturers of Ravulizumab
Table 4. Major Manufacturers of Others
Table 5. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Region (2018-2024)
Table 10. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Region (2024-2029)
Table 11. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2018-2024) & (K Units)
Table 13. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2024-2029) & (K Units)
Table 14. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region (2018-2024)
Table 15. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region (2024-2029)
Table 16. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Share by Manufacturers (2018-2024)
Table 18. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Paroxysmal Nocturnal Hemoglobinuria Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Paroxysmal Nocturnal Hemoglobinuria Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Paroxysmal Nocturnal Hemoglobinuria Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paroxysmal Nocturnal Hemoglobinuria Drug as of 2022)
Table 24. Global Key Manufacturers of Paroxysmal Nocturnal Hemoglobinuria Drug, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Paroxysmal Nocturnal Hemoglobinuria Drug, Product Offered and Application
Table 26. Global Key Manufacturers of Paroxysmal Nocturnal Hemoglobinuria Drug, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (K Units)
Table 29. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2024-2029) & (K Units)
Table 30. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Share by Type (2018-2024)
Table 31. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Share by Type (2024-2029)
Table 32. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Type (2018-2024)
Table 35. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Type (2024-2029)
Table 36. Paroxysmal Nocturnal Hemoglobinuria Drug Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Paroxysmal Nocturnal Hemoglobinuria Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) & (K Units)
Table 39. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2024-2029) & (K Units)
Table 40. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Share by Application (2018-2024)
Table 41. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Share by Application (2024-2029)
Table 42. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Application (2018-2024)
Table 45. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Application (2024-2029)
Table 46. Paroxysmal Nocturnal Hemoglobinuria Drug Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Paroxysmal Nocturnal Hemoglobinuria Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2024-2029) & (K Units)
Table 61. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (K Units)
Table 62. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2024-2029) & (K Units)
Table 63. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) & (K Units)
Table 66. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2024-2029) & (K Units)
Table 67. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2024) & (K Units)
Table 73. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2024-2029) & (K Units)
Table 74. China Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (K Units)
Table 75. China Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2024-2029) & (K Units)
Table 76. China Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) & (K Units)
Table 79. China Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2024-2029) & (K Units)
Table 80. China Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (K Units)
Table 83. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2024-2029) & (K Units)
Table 84. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) & (K Units)
Table 87. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2024-2029) & (K Units)
Table 88. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2018-2024) & (K Units)
Table 94. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2024-2029) & (K Units)
Table 108. Apellis Pharmaceuticals Company Information
Table 109. Apellis Pharmaceuticals Description and Major Businesses
Table 110. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Apellis Pharmaceuticals Recent Developments
Table 113. Alexion Pharmaceuticals Inc Company Information
Table 114. Alexion Pharmaceuticals Inc Description and Major Businesses
Table 115. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Alexion Pharmaceuticals Inc Recent Developments
Table 118. Akari Therapeutics Plc Company Information
Table 119. Akari Therapeutics Plc Description and Major Businesses
Table 120. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Akari Therapeutics Plc Recent Developments
Table 123. CinnaGen Co Company Information
Table 124. CinnaGen Co Description and Major Businesses
Table 125. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. CinnaGen Co Recent Developments
Table 128. Ra Pharmaceuticals Inc Company Information
Table 129. Ra Pharmaceuticals Inc Description and Major Businesses
Table 130. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Ra Pharmaceuticals Inc Recent Developments
Table 133. Amgen Inc Company Information
Table 134. Amgen Inc Description and Major Businesses
Table 135. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Amgen Inc Recent Developments
Table 138. Achillion Pharmaceuticals Inc Company Information
Table 139. Achillion Pharmaceuticals Inc Description and Major Businesses
Table 140. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Achillion Pharmaceuticals Inc Recent Developments
Table 143. Alnylam Pharmaceuticals Inc Company Information
Table 144. Alnylam Pharmaceuticals Inc Description and Major Businesses
Table 145. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Alnylam Pharmaceuticals Inc Recent Developments
Table 148. F. Hoffmann-La Roche Ltd Company Information
Table 149. F. Hoffmann-La Roche Ltd Description and Major Businesses
Table 150. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. F. Hoffmann-La Roche Ltd Recent Developments
Table 153. Novartis AG Company Information
Table 154. Novartis AG Description and Major Businesses
Table 155. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Novartis AG Recent Developments
Table 158. Regeneron Pharmaceuticals Inc Company Information
Table 159. Regeneron Pharmaceuticals Inc Description and Major Businesses
Table 160. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Regeneron Pharmaceuticals Inc Recent Developments
Table 163. BIOCAD Company Information
Table 164. BIOCAD Description and Major Businesses
Table 165. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. BIOCAD Recent Developments
Table 168. Samsung Bioepis Company Information
Table 169. Samsung Bioepis Description and Major Businesses
Table 170. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Samsung Bioepis Recent Developments
Table 173. Amyndas Pharmaceuticals Company Information
Table 174. Amyndas Pharmaceuticals Description and Major Businesses
Table 175. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Amyndas Pharmaceuticals Recent Developments
Table 178. Teva Pharmaceutical Industries Ltd. Company Information
Table 179. Teva Pharmaceutical Industries Ltd. Description and Major Businesses
Table 180. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 183. LGM Pharma. Company Information
Table 184. LGM Pharma. Description and Major Businesses
Table 185. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 186. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. LGM Pharma. Recent Developments
Table 188. Lannett Company Information
Table 189. Lannett Description and Major Businesses
Table 190. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 191. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Lannett Recent Developments
Table 193. NorthStar Rx LLC Company Information
Table 194. NorthStar Rx LLC Description and Major Businesses
Table 195. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 196. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. NorthStar Rx LLC Recent Developments
Table 198. Abbott Company Information
Table 199. Abbott Description and Major Businesses
Table 200. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 201. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 202. Abbott Recent Developments
Table 203. Par Pharmaceutical Company Information
Table 204. Par Pharmaceutical Description and Major Businesses
Table 205. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 206. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 207. Par Pharmaceutical Recent Developments
Table 208. Key Raw Materials Lists
Table 209. Raw Materials Key Suppliers Lists
Table 210. Paroxysmal Nocturnal Hemoglobinuria Drug Distributors List
Table 211. Paroxysmal Nocturnal Hemoglobinuria Drug Customers List
Table 212. Paroxysmal Nocturnal Hemoglobinuria Drug Market Trends
Table 213. Paroxysmal Nocturnal Hemoglobinuria Drug Market Drivers
Table 214. Paroxysmal Nocturnal Hemoglobinuria Drug Market Challenges
Table 215. Paroxysmal Nocturnal Hemoglobinuria Drug Market Restraints
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Paroxysmal Nocturnal Hemoglobinuria Drug Product Picture
Figure 2. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Type in 2022 & 2029
Figure 4. Eculizumab Product Picture
Figure 5. Ravulizumab Product Picture
Figure 6. Others Product Picture
Figure 7. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Application in 2022 & 2029
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Paroxysmal Nocturnal Hemoglobinuria Drug Report Years Considered
Figure 13. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue 2018-2029 (US$ Million)
Figure 15. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Region (2018-2029)
Figure 17. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales 2018-2029 ((K Units)
Figure 18. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Paroxysmal Nocturnal Hemoglobinuria Drug Sales YoY (2018-2029) & (K Units)
Figure 24. China Paroxysmal Nocturnal Hemoglobinuria Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Paroxysmal Nocturnal Hemoglobinuria Drug Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Paroxysmal Nocturnal Hemoglobinuria Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Paroxysmal Nocturnal Hemoglobinuria Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Paroxysmal Nocturnal Hemoglobinuria Drug in the World: Market Share by Paroxysmal Nocturnal Hemoglobinuria Drug Revenue in 2022
Figure 31. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Type (2018-2029)
Figure 33. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Type (2018-2029)
Figure 34. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application (2018-2029)
Figure 35. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Country (2018-2029)
Figure 41. US & Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales Share by Country (2018-2029)
Figure 42. U.S. Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Type (2018-2029)
Figure 45. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Type (2018-2029)
Figure 46. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application (2018-2029)
Figure 47. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Application (2018-2029)
Figure 48. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Country (2018-2029)
Figure 49. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Share by Country (2018-2029)
Figure 50. Germany Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 51. France Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 55. China Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Type (2018-2029)
Figure 56. China Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Type (2018-2029)
Figure 57. China Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application (2018-2029)
Figure 58. China Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Application (2018-2029)
Figure 59. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Type (2018-2029)
Figure 60. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Type (2018-2029)
Figure 61. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application (2018-2029)
Figure 62. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Application (2018-2029)
Figure 63. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Region (2018-2029)
Figure 64. Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales Share by Region (2018-2029)
Figure 65. Japan Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 69. India Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Share by Country (2018-2029)
Figure 76. Brazil Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2029) & (US$ Million)
Figure 81. Paroxysmal Nocturnal Hemoglobinuria Drug Value Chain
Figure 82. Paroxysmal Nocturnal Hemoglobinuria Drug Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figu